Cargando…
CSL362 potently and specifically depletes pDCs invitro and ablates SLE-immune complex-induced IFN responses
Systemic lupus erythematosus (SLE) is an autoimmune disease with significant morbidity and mortality. Type I interferon (IFN) drives SLE pathology and plasmacytoid dendritic cells (pDCs) are potent producers of IFN; however, the specific effects of pDC depletion have not been demonstrated. We show C...
Autores principales: | Monaghan, Katherine A., Hoi, Alberta, Gamell, Cristina, Tai, Tsin Yee, Linggi, Bryan, Jordan, Jarrat, Cesaroni, Matteo, Sato, Takahiro, Ng, Milica, Oon, Shereen, Benson, Jacqueline, Wicks, Ian, Morand, Eric, Wilson, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338305/ https://www.ncbi.nlm.nih.gov/pubmed/37456846 http://dx.doi.org/10.1016/j.isci.2023.107173 |
Ejemplares similares
-
Innate sensing of viral infection by pDCs and regulation by IFN-α and HMGB1 of TRAIL expression on pDCs and NK cells
por: Saïdi, Héla, et al.
Publicado: (2014) -
A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
por: Oon, Shereen, et al.
Publicado: (2019) -
Phenotypic and functional alterations of pDCs in lupus-prone mice
por: Zhou, Zhenyuan, et al.
Publicado: (2016) -
Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway
por: Oon, Shereen, et al.
Publicado: (2016) -
IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity
por: Lippens, Carla, et al.
Publicado: (2016)